Subscribe
Fair Drug Pricing & Increased Transparency
A Pharmacy Benefit Manager (PBM) is hired by health plans to manage drug programs. AWIR supports requiring PBMs to regularly report the difference between what they charge a health plan for a given drug and what it reimburses the pharmacy for dispensing it. Drug pricing has been a major issue in recent years that has continued to affect a patient’s ability to obtain their specialty medication.
To confront this issue AWIR has joined the Alliance for Transparent and Affordable Prescriptions (ATAP), which has been tasked to contest transparency in drug pricing on the state and federal level on behalf of patients and providers.
Prescription Drug for the People Act HR2376 — Tasks the FTC with studying the pharmaceutical supply chain and PBM merger activities.
Lower Health Care Costs Act S1895 (Sec. 306) — Requires PBMs to be transparent about the revenue they receive from manufacturers and ensures 100% of rebate savings will be passed onto plans.